m.almeida
TL2 Moderator · Nairobi
Contributes reviews on supplier material. Based in Nairobi.
Joined 23 September 2024 · last posted 4d
84Posts here
3Topics
0Solutions
120Likes received
113Likes given
20Badges
72Days visited
896Posts read
Recent activity
Full stream-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #12 · Compounds › Retatrutide · 24 Jul 2026 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #61 · Access › Insurance & coverage · 23 Jul 2026 · 3 likes This follows post #58 rather than contradicting it. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and…
-
[2026 update] Documenting an adverse event properly Replied, post #19 · Safety › Adverse events · 23 Jul 2026 · 0 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
Why the Start Here categories exist, and what they are not for Replied, post #17 · Start Here › Welcome · 20 Jul 2026 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #105 · Analytics › Home & field testing · 20 Jul 2026 · 26 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #102 · Sourcing › Independent verification · 18 Jul 2026 · 33 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Substitution between formats during a shortage — what changed since Replied, post #13 · Access › Shortages · 14 Jul 2026 · 3 likes post #12 is right about the mechanism and I think understates the practical bit. International supply chains: a shortage in one country does not mean shortage in…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #128 · Start Here › How to Ask · 14 Jul 2026 · 0 likes post #127 is right about the mechanism and I think understates the practical bit. What you have already read matters. Saying "I read the maintained page on this and I…
-
Common supplements people ask about, assessed one at a time Replied, post #23 · Practice › Interactions · 8 Jul 2026 · 0 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Journal club: what we got wrong in an earlier session Replied, post #52 · Evidence › Journal club · 4 Jul 2026 · 7 likes post #51 is right about the mechanism and I think understates the practical bit. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to…
-
Aggregate verification data across the directory, with caveats Replied, post #23 · Sourcing › Independent verification · 1 Jul 2026 · 13 likes This follows post #20 rather than contradicting it. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #75 · Analytics › Home & field testing · 30 Jun 2026 · 17 likes Coming back to post #73, because the follow-up matters more than the original answer. Why third-party testing is stronger: a home test run by the person who made the…